Lista de obras - Ahmed Idbaih - Dominio Público Uruguay

5th International Symposium on Focused Ultrasound: North Bethesda, MD, USA. 28 August- 1 September 2016.

artículo científico publicado en 2016

A New Landscape for Systemic Pharmacotherapy of Recurrent Glioblastoma?

scientific article published on 15 December 2020

A hypermethylated phenotype is a better predictor of survival than MGMT methylation in anaplastic oligodendroglial brain tumors: a report from EORTC study 26951.

artículo científico publicado en 2011

A novel tumor suppressor function of Kindlin-3 in solid cancer.

artículo científico publicado en 2014

A tumor growth inhibition model for low-grade glioma treated with chemotherapy or radiotherapy

artículo científico publicado en 2012

ASPM-associated stem cell proliferation is involved in malignant progression of gliomas and constitutes an attractive therapeutic target

artículo científico publicado en 2010

ATP binding cassette (ABC) transporters: expression and clinical value in glioblastoma

scientific article published on 08 March 2018

Allelic loss of 9p21.3 is a prognostic factor in 1p/19q codeleted anaplastic gliomas

artículo científico publicado en 2015

Alpha-internexin expression predicts outcome in anaplastic oligodendroglial tumors and may positively impact the efficacy of chemotherapy: European organization for research and treatment of cancer trial 26951.

artículo científico publicado en 2011

An ANOCEF genomic and transcriptomic microarray study of the response to irinotecan and bevacizumab in recurrent glioblastomas

artículo científico publicado en 2014

An ANOCEF genomic and transcriptomic microarray study of the response to radiotherapy or to alkylating first-line chemotherapy in glioblastoma patients

artículo científico publicado en 2010

Analysis of temozolomide resistance in low-grade gliomas using a mechanistic mathematical model

artículo científico publicado en 2016

Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile

artículo científico publicado en 2008

Array-based genomics in glioma research

artículo científico publicado en 2009

Association between glioma susceptibility loci and tumour pathology defines specific molecular etiologies

artículo científico publicado en 2012

BAC array CGH distinguishes mutually exclusive alterations that define clinicogenetic subtypes of gliomas.

artículo científico publicado en 2008

Basal Ganglia Germinoma in an Adult.

artículo científico publicado en 2016

Blood-brain barrier, cytotoxic chemotherapies and glioblastoma

artículo científico publicado en 2016

CRX is a diagnostic marker of retinal and pineal lineage tumors

artículo científico publicado en 2009

Chains of magnetosomes with controlled endotoxin release and partial tumor occupation induce full destruction of intracranial U87-Luc glioma in mice under the application of an alternating magnetic field.

artículo científico publicado en 2017

Changes in chromatin state reveal ARNT2 at a node of a tumorigenic transcription factor signature driving glioblastoma cell aggressiveness.

artículo científico publicado en 2017

Chromosome 17p Homodisomy Is Associated With Better Outcome in 1p19q Non-Codeleted and IDH-Mutated Gliomas.

artículo científico publicado en 2016

Chromosome 1p loss evaluation in anaplastic oligodendrogliomas

article

Chromosome 7p11.2 (EGFR) variation influences glioma risk

scientific journal article

Clinical Spectrum of Encephalitis Associated With Antibodies Against the α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptor: Case Series and Review of the Literature

artículo científico

Clinical course and MRI changes of basilar artery dolichoectasia: three case reports

scientific article published on 23 February 2004

Clinical value of chromosome arms 19q and 11p losses in low-grade gliomas

scientific article published on 12 December 2013

Correction to: ATP binding cassette (ABC) transporters: expression and clinical value in glioblastoma

artículo científico publicado en 2018

Correction: ASPM-associated stem cell proliferation is involved in malignant progression of gliomas and constitutes an attractive therapeutic target

artículo científico publicado en 2011

DGKI methylation status modulates the prognostic value of MGMT in glioblastoma patients treated with combined radio-chemotherapy with temozolomide

artículo científico publicado en 2014

DNA Methylation and Somatic Mutations Converge on the Cell Cycle and Define Similar Evolutionary Histories in Brain Tumors

artículo científico publicado en 2015

DNA fragmentation simulation method (FSM) and fragment size matching improve aCGH performance of FFPE tissues

artículo científico publicado en 2012

Deciphering the 8q24.21 association for glioma

artículo científico publicado en 2013

Detection, Characterization, and Inhibition of FGFR-TACC Fusions in IDH Wild-type Glioma.

artículo científico publicado en 2015

Development of non-pyrogenic magnetosome minerals coated with poly-l-lysine leading to full disappearance of intracranial U87-Luc glioblastoma in 100% of treated mice using magnetic hyperthermia.

artículo científico publicado en 2017

Diabetes Mellitus, Extreme Insulin Resistance, and Hypothalamic-Pituitary Langerhans Cells Histiocytosis

scientific article published on 23 June 2019

Diagnostic and prognostic value of alpha internexin expression in a series of 409 gliomas.

artículo científico publicado en 2010

Diagnostic and prognostic value of preoperative combined GFAP, IGFBP-2, and YKL-40 plasma levels in patients with glioblastoma

artículo científico publicado en 2014

Differential gene methylation in paired glioblastomas suggests a role of immune response pathways in tumor progression.

artículo científico publicado en 2015

Diffuse gliomas classified by 1p/19q co-deletion, TERT promoter and IDH mutation status are associated with specific genetic risk loci.

artículo científico publicado en 2018

Dramatic response of a BRAF V600E-mutated primary CNS histiocytic sarcoma to vemurafenib.

artículo científico publicado en 2014

Drug sensitivity of single cancer cells is predicted by changes in mass accumulation rate.

artículo científico publicado en 2016

Dural Arteriovenous Fistula Mimicking a Brainstem Glioma.

artículo científico publicado en 2015

Dural and osteolytic sarcomatoid relapse of a secondary gliosarcoma with tryptase immunoreactivity.

artículo científico publicado en 2016

EGFR Amplification and IDH Mutations in Glioblastoma Patients of the Northeast of Morocco

artículo científico publicado en 2017

Emerging circulating biomarkers in glioblastoma: promises and challenges.

artículo científico

Enhanced antitumor efficacy of biocompatible magnetosomes for the magnetic hyperthermia treatment of glioblastoma.

artículo científico publicado en 2017

French Intensive Care Society, International congress - Réanimation 2016

artículo científico publicado en 2016

Genetic risk profiles identify different molecular etiologies for glioma

artículo científico publicado en 2010

Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors

artículo científico publicado en 2017

Genomic aberrations associated with outcome in anaplastic oligodendroglial tumors treated within the EORTC phase III trial 26951

artículo científico publicado en 2010

Genomic changes in progression of low-grade gliomas

artículo científico publicado en 2008

Glioblastoma targeted therapy: updated approaches from recent biological insights

artículo científico

Glioma tumor grade correlates with parkin depletion in mutant p53-linked tumors and results from loss of function of p53 transcriptional activity.

artículo científico

IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group

artículo científico publicado en 2010

IDH1 gene mutations: a new paradigm in glioma prognosis and therapy?

artículo científico publicado en 2010

IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas.

artículo científico publicado en 2010

IDH2 mutations are commonly associated with 1p/19q codeletion in diffuse adult gliomas

Influence of MDM2 SNP309 alone or in combination with the TP53 R72P polymorphism in oligodendroglial tumors.

artículo científico publicado en 2008

Input of molecular analysis in medical management of primary brain tumor patients.

artículo científico

Insights revealed by high-throughput genomic arrays in nonglial primary brain tumors.

artículo científico

International Society for Therapeutic Ultrasound Conference 2016: Tel Aviv, Israel. 14-18 March, 2016.

artículo científico publicado en 2017

Intrinsic molecular subtypes of glioma are prognostic and predict benefit from adjuvant procarbazine, lomustine, and vincristine chemotherapy in combination with other prognostic factors in anaplastic oligodendroglial brain tumors: a report from EOR

artículo científico publicado en 2012

Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.

artículo científico publicado en 2009

Leptomeningeal Spread in Glioblastoma: Diagnostic and Therapeutic Challenges

scientific article published on 31 August 2020

Liquid Biopsy in Primary Brain Tumors: Looking for Stardust!

artículo científico publicado en 2018

Lomustine and Bevacizumab in Progressive Glioblastoma

artículo científico publicado en 2017

Long-term impact of temozolomide on 1p/19q-codeleted low-grade glioma growth kinetics.

artículo científico publicado en 2017

Low penetrance susceptibility to glioma is caused by the TP53 variant rs78378222.

artículo científico publicado en 2013

MGMT-STP27 methylation status as predictive marker for response to PCV in anaplastic Oligodendrogliomas and Oligoastrocytomas. A report from EORTC study 26951.

artículo científico

MRI features of neurodegenerative Langerhans cell histiocytosis

artículo científico publicado en 2006

MRI of Clot in Cerebral Venous Thrombosis

artículo científico publicado en 2006

Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial

artículo científico publicado en 2015

Mechanisms and therapeutic implications of hypermutation in gliomas

artículo científico publicado en 2020

Methylation profiling identifies 2 groups of gliomas according to their tumorigenesis

artículo científico publicado en 2010

Mitotic index, microvascular proliferation, and necrosis define 3 groups of 1p/19q codeleted anaplastic oligodendrogliomas associated with different genomic alterations

artículo científico publicado en 2014

Molecular analysis of diffuse intrinsic brainstem gliomas in adults.

artículo científico publicado en 2013

Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial.

artículo científico publicado en 2015

Molecular profiling of gliomas: potential therapeutic implications.

artículo científico

Multi-omics analysis of primary glioblastoma cell lines shows recapitulation of pivotal molecular features of parental tumors.

artículo científico publicado en 2016

Multi-platform molecular profiling of a large cohort of glioblastomas reveals potential therapeutic strategies

artículo científico publicado en 2016

Mutational analysis of Rac2 in gliomas.

artículo científico publicado en 2008

Myxoid malignant fibrous histiocytoma and pleomorphic liposarcoma share very similar genomic imbalances

artículo científico publicado en 2005

NOTCH2 is neither rearranged nor mutated in t(1;19) positive oligodendrogliomas

artículo científico publicado en 2009

Neuro-oncology: Novel molecular targets in treatment of glioblastoma.

artículo científico publicado en 2013

Neuro-oncology: anaplastic oligodendrogliomas-value of early chemotherapy.

artículo científico publicado en 2012

Neurolymphomatosis as a relapse of primary cerebral nervous system lymphoma

artículo científico publicado en 2016

Nitrosourea-based chemotherapy for low grade gliomas failing initial treatment with temozolomide.

artículo científico publicado en 2010

No association of MDM2 SNP309 with risk of glioblastoma and prognosis

artículo científico publicado en 2007

OMICS and biomarkers of glial tumors ⬇️

artículo científico publicado el 1 de septiembre de 2011

Ongoing and prolonged response in adult low-grade gliomas treated with radiotherapy.

artículo científico publicado en 2013

PATH-16. MOLECULAR PATHOLOGY AND CLINICAL CHARACTERISTICS OF MMR DEFICIENCY (MMRd) IN DIFFUSE GLIOMAS

Patterns of response to crizotinib in recurrent glioblastoma according to ALK and MET molecular profile in two patients

artículo científico publicado en 2015

Phenotypes and survival in Erdheim-Chester disease: Results from a 165-patient cohort

artículo científico publicado en 2018

Phenotypic selection through cell death: stochastic modelling of O-6-methylguanine-DNA methyltransferase dynamics

artículo científico publicado en 2020

Preclinical Efficacy of the MDM2 Inhibitor RG7112 in MDM2-Amplified and TP53 Wild-type Glioblastomas

artículo científico publicado en 2015

Preclinical impact of bevacizumab on brain and tumor distribution of irinotecan and temozolomide.

artículo científico publicado en 2015

Prediction of Response to Temozolomide in Low-Grade Glioma Patients Based on Tumor Size Dynamics and Genetic Characteristics

artículo científico

Predictive biomarkers investigated in glioblastoma.

artículo científico

Prevalence of hepatitis B virus in primary central nervous system lymphoma

artículo científico publicado en 2015

Primary brain tumours in adults

artículo científico publicado en 2012

Profiling Anti-Apoptotic BCL-xL Protein Expression in Glioblastoma Tumorspheres

artículo científico publicado en 2020

Prognosis of patients with primary malignant brain tumors admitted to the intensive care unit: a two-decade experience

artículo científico publicado en 2017

Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohort

artículo científico publicado en 2016

Prognostic impact of the isocitrate dehydrogenase 1 single-nucleotide polymorphism rs11554137 in malignant gliomas.

artículo científico publicado en 2012

Prophylactic intrathecal chemotherapy in primary CNS lymphoma

artículo científico publicado en 2011

Proton magnetic resonance spectroscopy predicts proliferative activity in diffuse low-grade gliomas

artículo científico publicado en 2007

Quantifying the heritability of glioma using genome-wide complex trait analysis

artículo científico publicado en 2015

Recurrent Glioblastoma: From Molecular Landscape to New Treatment Perspectives

artículo científico publicado en 2020

Recurrent mutations of MYD88 and TBL1XR1 in primary central nervous system lymphomas

artículo científico publicado en 2012

Retinoic acid therapy in "degenerative-like" neuro-langerhans cell histiocytosis: a prospective pilot study

artículo científico publicado en 2004

SNP array analysis reveals novel genomic abnormalities including copy neutral loss of heterozygosity in anaplastic oligodendrogliomas

artículo científico publicado en 2012

Same-day genomic and epigenomic diagnosis of brain tumors using real-time nanopore sequencing

artículo científico publicado en 2017

Short course of radiation therapy in elderly patients with glioblastoma multiforme

scientific article published on 28 November 2008

Spatial and temporal evolution of distal 10q deletion, a prognostically unfavorable event in diffuse low-grade gliomas

artículo científico publicado en 2014

Structural and functional intratumor heterogeneities in glioblastoma: a spacetime odyssey at single-cell level.

artículo científico publicado en 2017

TCF12 is mutated in anaplastic oligodendroglioma

artículo científico publicado en 2015

TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations

artículo científico publicado en 2014

TP53 and p53 statuses and their clinical impact in diffuse low grade gliomas.

artículo científico publicado en 2014

TP53 codon 72 polymorphism, p53 expression, and 1p/19q status in oligodendroglial tumors

scientific article published on 01 September 2007

TP53 mutations but no CHEK2 *1100DelC variant in familial gliomas.

artículo científico publicado en 2009

Targeted therapies in 54 patients with Erdheim-Chester disease, including follow-up after interruption (the LOVE study).

artículo científico publicado en 2017

Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome

artículo científico publicado en 2007

Temporary blood-brain barrier disruption by low intensity pulsed ultrasound increases carboplatin delivery and efficacy in preclinical models of glioblastoma

artículo científico publicado en 2019

The cognitive spectrum in neurodegenerative Langerhans cell histiocytosis.

artículo científico publicado en 2014

Tumor and endothelial cell hybrids participate in glioblastoma vasculature

artículo científico publicado en 2014

Tumor genomic profiling and TP53 germline mutation analysis of first-degree relative familial gliomas

artículo científico publicado en 2007

Two types of chromosome 1p losses with opposite significance in gliomas

artículo científico publicado en 2005

Up-front temozolomide in elderly patients with anaplastic oligodendroglioma and oligoastrocytoma.

artículo científico publicado en 2010

[Adult diffuse glioma: genetic heterogeneity and therapeutic implications].

artículo científico publicado en 2012

[Genetics and brain gliomas].

artículo científico publicado en 2012

[Medulloblastomas: review].

artículo científico publicado en 2011

[Mixed histiocytosis, a rare cause of stroke].

artículo científico publicado en 2015

[Nutritional status in patients with recurrent glioblastoma].

artículo científico publicado en 2013

[Radiotherapy in central neurocytoma and review of literature]

artículo científico publicado en 2014

[Should elderly patients with glioblastoma be proposed to radiotherapy?]

artículo científico publicado en 2008

alpha-Internexin expression identifies 1p19q codeleted gliomas.

artículo científico publicado en 2009

Lista de obras de Ahmed Idbaih

5th International Symposium on Focused Ultrasound: North Bethesda, MD, USA. 28 August- 1 September 2016.

A New Landscape for Systemic Pharmacotherapy of Recurrent Glioblastoma?

A hypermethylated phenotype is a better predictor of survival than MGMT methylation in anaplastic oligodendroglial brain tumors: a report from EORTC study 26951.

A novel tumor suppressor function of Kindlin-3 in solid cancer.

A tumor growth inhibition model for low-grade glioma treated with chemotherapy or radiotherapy

ASPM-associated stem cell proliferation is involved in malignant progression of gliomas and constitutes an attractive therapeutic target

ATP binding cassette (ABC) transporters: expression and clinical value in glioblastoma

Allelic loss of 9p21.3 is a prognostic factor in 1p/19q codeleted anaplastic gliomas

Alpha-internexin expression predicts outcome in anaplastic oligodendroglial tumors and may positively impact the efficacy of chemotherapy: European organization for research and treatment of cancer trial 26951.

An ANOCEF genomic and transcriptomic microarray study of the response to irinotecan and bevacizumab in recurrent glioblastomas

An ANOCEF genomic and transcriptomic microarray study of the response to radiotherapy or to alkylating first-line chemotherapy in glioblastoma patients

Analysis of temozolomide resistance in low-grade gliomas using a mechanistic mathematical model

Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile

Array-based genomics in glioma research

Association between glioma susceptibility loci and tumour pathology defines specific molecular etiologies

BAC array CGH distinguishes mutually exclusive alterations that define clinicogenetic subtypes of gliomas.

Basal Ganglia Germinoma in an Adult.

Blood-brain barrier, cytotoxic chemotherapies and glioblastoma

CRX is a diagnostic marker of retinal and pineal lineage tumors

Chains of magnetosomes with controlled endotoxin release and partial tumor occupation induce full destruction of intracranial U87-Luc glioma in mice under the application of an alternating magnetic field.

Changes in chromatin state reveal ARNT2 at a node of a tumorigenic transcription factor signature driving glioblastoma cell aggressiveness.

Chromosome 17p Homodisomy Is Associated With Better Outcome in 1p19q Non-Codeleted and IDH-Mutated Gliomas.

Chromosome 1p loss evaluation in anaplastic oligodendrogliomas

Chromosome 7p11.2 (EGFR) variation influences glioma risk

Clinical Spectrum of Encephalitis Associated With Antibodies Against the α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptor: Case Series and Review of the Literature

Clinical course and MRI changes of basilar artery dolichoectasia: three case reports

Clinical value of chromosome arms 19q and 11p losses in low-grade gliomas

Correction to: ATP binding cassette (ABC) transporters: expression and clinical value in glioblastoma

Correction: ASPM-associated stem cell proliferation is involved in malignant progression of gliomas and constitutes an attractive therapeutic target

DGKI methylation status modulates the prognostic value of MGMT in glioblastoma patients treated with combined radio-chemotherapy with temozolomide

DNA Methylation and Somatic Mutations Converge on the Cell Cycle and Define Similar Evolutionary Histories in Brain Tumors

DNA fragmentation simulation method (FSM) and fragment size matching improve aCGH performance of FFPE tissues

Deciphering the 8q24.21 association for glioma

Detection, Characterization, and Inhibition of FGFR-TACC Fusions in IDH Wild-type Glioma.

Development of non-pyrogenic magnetosome minerals coated with poly-l-lysine leading to full disappearance of intracranial U87-Luc glioblastoma in 100% of treated mice using magnetic hyperthermia.

Diabetes Mellitus, Extreme Insulin Resistance, and Hypothalamic-Pituitary Langerhans Cells Histiocytosis

Diagnostic and prognostic value of alpha internexin expression in a series of 409 gliomas.

Diagnostic and prognostic value of preoperative combined GFAP, IGFBP-2, and YKL-40 plasma levels in patients with glioblastoma

Differential gene methylation in paired glioblastomas suggests a role of immune response pathways in tumor progression.

Diffuse gliomas classified by 1p/19q co-deletion, TERT promoter and IDH mutation status are associated with specific genetic risk loci.

Dramatic response of a BRAF V600E-mutated primary CNS histiocytic sarcoma to vemurafenib.

Drug sensitivity of single cancer cells is predicted by changes in mass accumulation rate.

Dural Arteriovenous Fistula Mimicking a Brainstem Glioma.

Dural and osteolytic sarcomatoid relapse of a secondary gliosarcoma with tryptase immunoreactivity.

EGFR Amplification and IDH Mutations in Glioblastoma Patients of the Northeast of Morocco

Emerging circulating biomarkers in glioblastoma: promises and challenges.

Enhanced antitumor efficacy of biocompatible magnetosomes for the magnetic hyperthermia treatment of glioblastoma.

French Intensive Care Society, International congress - Réanimation 2016

Genetic risk profiles identify different molecular etiologies for glioma

Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors

Genomic aberrations associated with outcome in anaplastic oligodendroglial tumors treated within the EORTC phase III trial 26951

Genomic changes in progression of low-grade gliomas

Glioblastoma targeted therapy: updated approaches from recent biological insights

Glioma tumor grade correlates with parkin depletion in mutant p53-linked tumors and results from loss of function of p53 transcriptional activity.

IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group

IDH1 gene mutations: a new paradigm in glioma prognosis and therapy?

IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas.

IDH2 mutations are commonly associated with 1p/19q codeletion in diffuse adult gliomas

Influence of MDM2 SNP309 alone or in combination with the TP53 R72P polymorphism in oligodendroglial tumors.

Input of molecular analysis in medical management of primary brain tumor patients.

Insights revealed by high-throughput genomic arrays in nonglial primary brain tumors.

International Society for Therapeutic Ultrasound Conference 2016: Tel Aviv, Israel. 14-18 March, 2016.

Intrinsic molecular subtypes of glioma are prognostic and predict benefit from adjuvant procarbazine, lomustine, and vincristine chemotherapy in combination with other prognostic factors in anaplastic oligodendroglial brain tumors: a report from EOR

Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.

Leptomeningeal Spread in Glioblastoma: Diagnostic and Therapeutic Challenges

Liquid Biopsy in Primary Brain Tumors: Looking for Stardust!

Lomustine and Bevacizumab in Progressive Glioblastoma

Long-term impact of temozolomide on 1p/19q-codeleted low-grade glioma growth kinetics.

Low penetrance susceptibility to glioma is caused by the TP53 variant rs78378222.

MGMT-STP27 methylation status as predictive marker for response to PCV in anaplastic Oligodendrogliomas and Oligoastrocytomas. A report from EORTC study 26951.

MRI features of neurodegenerative Langerhans cell histiocytosis

MRI of Clot in Cerebral Venous Thrombosis

Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial

Mechanisms and therapeutic implications of hypermutation in gliomas

Methylation profiling identifies 2 groups of gliomas according to their tumorigenesis

Mitotic index, microvascular proliferation, and necrosis define 3 groups of 1p/19q codeleted anaplastic oligodendrogliomas associated with different genomic alterations

Molecular analysis of diffuse intrinsic brainstem gliomas in adults.

Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial.

Molecular profiling of gliomas: potential therapeutic implications.